Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer
Clinical trial NCT00874588 · COMPLETED
Trial details
- NCT number
- NCT00874588
- Sponsor
- Fukushima Medical University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2012-06-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.